1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Guided Therapeutics

Anonymous board for Guided Therapeutics

Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    0
    Views:
    4,182
  2. Anonymous
    Replies:
    1
    Views:
    2,615
  3. vsun
    Replies:
    2
    Views:
    2,983
  4. Anonymous
    Replies:
    0
    Views:
    2,331
  5. Anonymous
    Replies:
    1
    Views:
    4,385
  6. Anonymous
    Replies:
    0
    Views:
    2,732
  7. Anonymous
    Replies:
    10
    Views:
    7,485
  8. Anonymous
    Replies:
    0
    Views:
    3,080
  9. Anonymous
    Replies:
    2
    Views:
    4,380
  10. Anonymous
    Replies:
    1
    Views:
    4,829

Thread Display Options

Loading...